PMID- 34432202
OWN - NLM
STAT- MEDLINE
DCOM- 20211125
LR  - 20211125
IS  - 1993-0402 (Electronic)
IS  - 1672-0415 (Linking)
VI  - 27
IP  - 10
DP  - 2021 Oct
TI  - Inokosterone Is A Potential Drug Target of Estrogen Receptor 1 in Rheumatoid 
      Arthritis Patients: Analysis from Active Ingredient of Cyathula Officinalis.
PG  - 767-773
LID - 10.1007/s11655-021-3492-5 [doi]
AB  - OBJECTIVE: To elucidate the active compounds and the molecular mechanism of 
      Cyathula Officinalis as a drug treatment for rheumatoid arthritis (RA). METHODS: 
      The target genes of active ingredients from Cyathula Officinalis were obtained 
      from bioinformatics analysis tool for the molecular mechanism of traditional 
      Chinese medicine. The protein-protein interaction between the target genes were 
      analyzed using STRING and Genemania. The transcriptome of RA patients compared to 
      healthy people (GSE121894) were analyzed using R program package Limma. The 
      relative expression of the target genes was obtained from the RNA-seq datasets. 
      The molecular docking analyses were processed based on the molecular model of 
      estrogen receptor 1 (ESR1) binding with estradiol (PDB ID:1A52). The binding 
      details were analyzed by SYBYL. RESULTS: Inokosterone, ecdysterone, and cyaterone 
      were the 3 active ingredients from Cyathula Officinalis that bind to target 
      genes. Of all the significantly changed genes from RA patients, ESR1, ADORA1, and 
      ANXA1 were significantly increased in mRNA samples of RA patients. CONCLUSION: 
      ESR1, the transcription factor that binds inokosterone in the molecular binding 
      analysis, is the target protein of Cyathula Officinalis.
CI  - (c) 2021. The Chinese Journal of Integrated Traditional and Western Medicine Press 
      and Springer-Verlag GmbH Germany, part of Springer Nature.
FAU - Mo, Ji-Hao
AU  - Mo JH
AD  - Department of Medical Laboratory, Luoyang Orthopedic Hospital of Henan Province, 
      Orthopedic Institute of Henan Province, Luoyang, Henan Province, 471002, China.
FAU - Xie, Han-Kun
AU  - Xie HK
AD  - Miller School of Medicine, University of Miami, Miami, FL, 33136, USA.
FAU - Zhou, Ye-Mian
AU  - Zhou YM
AD  - Institute of Technical Biology & Agriculture Engineering, Hefei Institutes of 
      Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.
FAU - Ng, Sihan-Benjamin
AU  - Ng SB
AD  - Eatobe Pte. Limited, 573969, Singapore, Singapore.
FAU - Li, Shao-Xia
AU  - Li SX
AD  - Department of Medical Laboratory, Luoyang Orthopedic Hospital of Henan Province, 
      Orthopedic Institute of Henan Province, Luoyang, Henan Province, 471002, China.
FAU - Wang, Lei
AU  - Wang L
AD  - Miller School of Medicine, University of Miami, Miami, FL, 33136, USA. 
      lxw561@miami.edu.
LA  - eng
PT  - Journal Article
DEP - 20210825
PL  - China
TA  - Chin J Integr Med
JT  - Chinese journal of integrative medicine
JID - 101181180
RN  - 0 (Cholestenes)
RN  - 0 (Estrogen Receptor alpha)
RN  - 0 (Pharmaceutical Preparations)
RN  - 15130-85-5 (inokosterone)
SB  - IM
MH  - *Arthritis, Rheumatoid/drug therapy/genetics
MH  - Cholestenes
MH  - Estrogen Receptor alpha
MH  - Humans
MH  - Molecular Docking Simulation
MH  - *Pharmaceutical Preparations
OTO - NOTNLM
OT  - Chinese medicine
OT  - Cyathula Officinalis
OT  - estrogen receptor 1
OT  - inokosterone
OT  - rheumatoid arthritis
EDAT- 2021/08/26 06:00
MHDA- 2021/11/26 06:00
CRDT- 2021/08/25 12:28
PHST- 2020/05/11 00:00 [accepted]
PHST- 2021/08/26 06:00 [pubmed]
PHST- 2021/11/26 06:00 [medline]
PHST- 2021/08/25 12:28 [entrez]
AID - 10.1007/s11655-021-3492-5 [pii]
AID - 10.1007/s11655-021-3492-5 [doi]
PST - ppublish
SO  - Chin J Integr Med. 2021 Oct;27(10):767-773. doi: 10.1007/s11655-021-3492-5. Epub 
      2021 Aug 25.